Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 0.1747 |
| Open | 0.1750 |
| Bid | 0.1750 x 1100 |
| Ask | 0.0000 x 900 |
| Day's range | 0.1715 - 0.1880 |
| 52-week range | 0.1000 - 0.6240 |
| Volume | |
| Avg. volume | 4,133,450 |
| Market cap | 21.486M |
| Beta (5Y monthly) | 2.03 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
Industry veteran brings extensive experience in the development and commercialization of advanced biological therapies, including in the field of complement (C5)NEW YORK and LONDON, March 02, 2022 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LBT4) systems are implicated, today announced the appointment of Rachelle
© 2023 Yahoo. All rights reserved.
